MNPR
NASDAQ · Biotechnology
Monopar Therapeutics Inc
$95.72
-0.75 (-0.78%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-56.8% upside
Low Target
$22.89
Average Target
$41.31
High Target
$45.20
Current Price
$95.72
Current
$95.72
$95.72
Target
$41.31
$41.31
$22.89
$41.31 avg
$45.20
Scenario Analysis
Bear Case
$22.89
-76.1%
Low target
Base Case
$41.31
-56.8%
Avg target
Bull Case
$45.20
+-52.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$124.82
-23.3% from high
52-Week Low
$50.07
+91.2% from low
Target vs 52W High
$41.31
-66.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |